Contact this trialFirst, we need to learn more about you.
Stent
Stents + Rosiglitazone for Coronary Artery Disease in Diabetics
Recruiting1 awardPhase 2 & 3
Boston, Massachusetts
This trial will test whether a combination of two different types of stents and an oral diabetes drug will reduce restenosis (reexcessive growth of tissue) after stenting in type 2 diabetic patients.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.